Top CNS and Pain Drug Classes for Pharmacy Techs
Educational only, not medical advice. This guide explains general US pharmacy-technician topics. Follow your training, your pharmacist, your state board and the official references for real patients.
Medicines that act on the brain and nervous system include many of the most dispensed drugs in community pharmacy, and many of them are controlled substances. For a technician, that means two jobs: recognizing the drug class from the generic name, and knowing which federal schedule applies, because the schedule changes how the prescription may be filled, refilled and stored. This guide covers the main classes with generic examples, federal schedules taken from DEA regulations, and the safety points worth flagging to the pharmacist. It describes US federal law only; many state boards of pharmacy are stricter.
| Class | Generic examples | Federal schedule |
|---|---|---|
| SSRIs, SNRIs, other antidepressants | sertraline, duloxetine, bupropion, trazodone | not controlled |
| Benzodiazepines | alprazolam, lorazepam, clonazepam, diazepam, temazepam | C-IV |
| Opioid analgesics | oxycodone, hydrocodone (including combinations), morphine, fentanyl, methadone | C-II |
| Other opioids | buprenorphine (C-III); tramadol (C-IV) | C-III / C-IV |
| ADHD stimulants | methylphenidate, dexmethylphenidate, amphetamine, lisdexamfetamine | C-II |
| ADHD nonstimulants | atomoxetine, guanfacine extended release | not controlled |
| Anticonvulsants | most not controlled; pregabalin, lacosamide, brivaracetam, cenobamate (C-V); clobazam, phenobarbital (C-IV) | varies |
| Prescription sleep aids | zolpidem, eszopiclone, zaleplon, suvorexant, lemborexant, daridorexant (C-IV, proposed C-V); ramelteon (not controlled) | varies |
Federal refill rules follow the schedule. Schedule II prescriptions cannot be refilled; a prescriber may instead issue multiple Schedule II prescriptions covering up to a 90-day supply. Schedule III and IV prescriptions may be refilled up to five times within six months of the date written, if the prescriber authorizes refills.
Antidepressants
- SSRIs (selective serotonin reuptake inhibitors): fluoxetine, sertraline, paroxetine, citalopram, escitalopram.
- SNRIs (serotonin-norepinephrine reuptake inhibitors): venlafaxine, desvenlafaxine, duloxetine.
- Others: bupropion, mirtazapine, trazodone, tricyclics such as amitriptyline and nortriptyline, and MAO inhibitors such as phenelzine.
Points to recognize:
- Boxed warning. Antidepressants carry a boxed warning about increased suicidal thoughts and behavior in children, adolescents and young adults (through age 24), especially early in treatment.
- Serotonin syndrome. Combining serotonergic drugs can cause this potentially life-threatening reaction. Fluoxetine's label contraindicates starting a psychiatric MAO inhibitor within 5 weeks of stopping fluoxetine, and starting fluoxetine within 14 days of stopping one.
- Bupropion and seizures. Seizure risk rises with dose. Bupropion is contraindicated in seizure disorders and in current or past bulimia or anorexia nervosa. Because it is also prescribed for smoking cessation, watch for two bupropion products on one profile.
Benzodiazepines
Benzodiazepines enhance GABA, the brain's main calming signal. They treat anxiety, panic disorder, seizures and alcohol withdrawal. Examples: alprazolam, lorazepam, clonazepam, diazepam, temazepam. All are Schedule IV.
Points to recognize:
- In 2020 the FDA required the class boxed warning to cover abuse, misuse, addiction, physical dependence and withdrawal reactions. Stopping suddenly or tapering too fast can cause serious withdrawal, so dose reductions are gradual.
- Benzodiazepines and opioids together can cause profound sedation, slowed breathing, coma and death; both classes carry a boxed warning about this. An opioid and a benzodiazepine on the same profile should always reach the pharmacist.
Opioid analgesics
Opioids bind opioid receptors to relieve moderate to severe pain. Most are Schedule II: oxycodone, hydrocodone, morphine, hydromorphone, fentanyl, methadone. Two scheduling changes from 2014 still appear on exams:
- Hydrocodone combination products (for example, hydrocodone with acetaminophen) moved from Schedule III to Schedule II, effective October 6, 2014.
- Tramadol was placed in Schedule IV, effective August 18, 2014.
Buprenorphine is Schedule III, and codeine combined with acetaminophen in tablets is Schedule III, while single-ingredient codeine is Schedule II.
Points to recognize:
- Opioid boxed warnings include addiction, abuse and misuse; life-threatening respiratory depression; accidental ingestion, especially by children; neonatal opioid withdrawal syndrome; and the benzodiazepine interaction.
- Constipation is common, and total daily acetaminophen from combination and OTC products adds up.
- Naloxone reverses opioid overdose. In March 2023 the FDA approved the first naloxone nasal spray for sale without a prescription (4 mg).
- Technicians help with Schedule II paperwork, counts and storage, but judging whether a controlled substance prescription is legitimate is the pharmacist's responsibility.
Stimulants and nonstimulants for ADHD
Stimulants increase dopamine and norepinephrine activity. Methylphenidate, dexmethylphenidate, amphetamine salts and lisdexamfetamine are all Schedule II, so no refills. They carry boxed warnings about abuse, misuse and addiction. Nonstimulant options such as atomoxetine and extended-release guanfacine are not federally controlled. Note that atomoxetine shares the -oxetine ending with fluoxetine but is an ADHD drug, not an antidepressant.
Anticonvulsants
Anticonvulsants (antiseizure medicines) calm abnormal electrical activity in the brain; several are also labeled for nerve pain or mood disorders. Examples: levetiracetam, lamotrigine, carbamazepine, oxcarbazepine, phenytoin, valproate (divalproex), topiramate, gabapentin and pregabalin.
Points to recognize:
- Scheduling varies. Pregabalin, lacosamide, brivaracetam and cenobamate are Schedule V; clobazam and phenobarbital are Schedule IV. Gabapentin is not federally controlled, but several states schedule it or require prescription monitoring reporting.
- Lamotrigine has a boxed warning for serious, potentially fatal rashes; the risk rises if the starting dose or dose increases go faster than recommended, or with valproate.
- Carbamazepine has boxed warnings for serious skin reactions linked to the HLA-B\*1502 gene variant and for rare blood disorders.
- Valproate has boxed warnings for liver failure, fetal harm (including neural tube defects) and pancreatitis.
Sleep aids
- "Z-drugs": zolpidem, eszopiclone, zaleplon. Schedule IV. Since 2019 they carry a boxed warning for complex sleep behaviors such as sleepwalking and sleep-driving, and they are contraindicated in anyone who has had such an episode on one of them.
- Orexin receptor antagonists: suvorexant, lemborexant, daridorexant. Schedule IV for now; DEA proposed in August 2026 to move them to Schedule V.
- Ramelteon, a melatonin receptor agonist, is not controlled.
- OTC antihistamines such as diphenhydramine and doxylamine are sold as nonprescription sleep aids and can cause next-day drowsiness.
Key takeaways
- Antidepressants are not controlled, but watch for serotonin syndrome combinations and the boxed warning for young patients.
- Benzodiazepines and Z-drugs are Schedule IV; most opioid analgesics and ADHD stimulants are Schedule II with no refills.
- Hydrocodone combinations are Schedule II and tramadol is Schedule IV, both since 2014.
- Opioid plus benzodiazepine is a boxed-warning combination to flag every time.
- Anticonvulsant schedules vary: pregabalin is C-V, clobazam is C-IV, and gabapentin is not federally controlled.
Quick check
Q1. A prescription for hydrocodone with acetaminophen arrives with "refills: 2." What is the federal rule?
Answer: It cannot be refilled. Hydrocodone combination products are Schedule II, and Schedule II prescriptions may not be refilled.
Q2. Which is Schedule V: pregabalin, gabapentin or clonazepam?
Answer: Pregabalin. Gabapentin is not federally controlled, and clonazepam is a Schedule IV benzodiazepine.
Q3. A profile shows a new oxycodone prescription and an existing alprazolam prescription. Why flag it?
Answer: Opioids combined with benzodiazepines can cause profound sedation and fatal respiratory depression, a boxed warning for both classes.
Practice these classes and schedules in Pillworks Idle.
Sources
- eCFR — 21 CFR 1308.14, Schedule IV
- eCFR — 21 CFR 1308.15, Schedule V
- DEA Diversion Control Division — Pharmacist's Manual
- Federal Register — Rescheduling of hydrocodone combination products from Schedule III to Schedule II (2014)
- Federal Register — Placement of tramadol into Schedule IV (2014)
- FDA — Boxed Warning updated to improve safe use of the benzodiazepine drug class
- FDA — Certain prescription insomnia medicines, new Boxed Warning for complex sleep behaviors
- FDA — FDA approves first over-the-counter naloxone nasal spray